tiprankstipranks

CHRISTOPHER P KIRITSY Insider Profile

4 Followers
CHRISTOPHER P KIRITSY, Director at Palvella Therapeutics, holds 250.00 shares in Palvella Therapeutics (Ticker: PVLA), holds ― shares in HTG Molecular Diagnostics (Ticker: HTGMQ).
tipranks
CHRISTOPHER P KIRITSY

CHRISTOPHER P KIRITSY
Palvella Therapeutics (PVLA)
Director

Ranked #83,212 out of 108,921 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-25.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$38K
100.00%
0.00%
A breakdown of CHRISTOPHER P KIRITSY's holdings

Insider Roles

Palvella Therapeutics
(PVLA)
Director
HTG Molecular Diagnostics
(HTGMQ)
Director
Roles that CHRISTOPHER P KIRITSY holds in companies

Most Profitable Insider Trade

Stock:
Palvella Therapeutics
(PVLA)
Rating:Informative Buy
Date:Sep 17, 2018 - Sep 17, 2019
Return:+6.80%
The most profitable trade made by CHRISTOPHER P KIRITSY

CHRISTOPHER P KIRITSY's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Palvella Therapeutics
Sep 04, 2026
Director
Uninformative Buy
39.81K
$37.60K
HTG Molecular Diagnostics
Director
List of latest transactions for each holding click on a transaction to see CHRISTOPHER P KIRITSY's performance on stock

CHRISTOPHER P KIRITSY insider profile FAQ

What is the percentage of profitable transactions made by CHRISTOPHER P KIRITSY?
The percentage of profitable transactions made by CHRISTOPHER P KIRITSY is 33%.
    What is the average return per transaction made by CHRISTOPHER P KIRITSY?
    The average return per transaction made by CHRISTOPHER P KIRITSY is -25.60%.
      What stocks does CHRISTOPHER P KIRITSY hold?
      CHRISTOPHER P KIRITSY holds: PVLA, HTGMQ stocks.
        What was CHRISTOPHER P KIRITSY’s latest transaction?
        CHRISTOPHER P KIRITSY latest transaction was an Uninformative Buy of $39.81K.
          What was CHRISTOPHER P KIRITSY's most profitable transaction?
          CHRISTOPHER P KIRITSY’s most profitable transaction was an Informative Buy of PVLA stock on September 17, 2018. The return on the trade was 6.80%.
            What is CHRISTOPHER P KIRITSY's role in Palvella Therapeutics?
            CHRISTOPHER P KIRITSY's role in Palvella Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.